Bovine respiratory syncytial virus (BRSV) forms syncytial cells in cattle and is related to human BRSV. It has a high morbidity rate among calves aged 0-20 weeks and is transmitted via respiratory aerosols or direct contact. Vaccination for BRSV lacks efficiency and some research has shown apparent disease enhancement upon challenge. Diagnosis involves nasal swabs within 6 days of infection and gross necropsy may show severe pulmonary edema and interstitial emphysema. Treatment focuses on supportive care, antimicrobials, and anti-inflammatory drugs. Vaccination is recommended after maternal antibodies decline using inactivated or modified live vaccines but protection is short-lived requiring frequent revaccination.